IRulya Therapeutics, Inc. (IRLA)
34.17
+3.17
(+10.23%)
USD |
NASDAQ |
Nov 09, 16:00
33.80
-0.37
(-1.08%)
After-Hours: 18:50
IRulya Therapeutics Gross Profit (Annual) : -0.142M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.142M |
| December 31, 2024 | -0.186M |
| December 31, 2023 | -0.322M |
| December 31, 2022 | -0.175M |
| December 31, 2021 | -0.344M |
| Date | Value |
|---|---|
| December 31, 2020 | -0.332M |
| December 31, 2019 | -0.188M |
| December 31, 2018 | -0.051M |
| December 31, 2017 | -0.045M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Korsana Biosciences, Inc. | 0.00 |
| PepGen Inc. | -1.397M |
| Q32 Bio, Inc. | 53.35M |
| Bridgebio Oncology Therapeutics, Inc. | -0.61M |
| Arrowhead Pharmaceuticals, Inc. | 805.52M |